Literature DB >> 29748285

An anatomic transcriptional atlas of human glioblastoma.

Ralph B Puchalski1,2, Nameeta Shah3,4, Jeremy Miller5, Rachel Dalley5, Steve R Nomura2, Jae-Guen Yoon2, Kimberly A Smith5, Michael Lankerovich2, Darren Bertagnolli5, Kris Bickley5, Andrew F Boe5, Krissy Brouner5, Stephanie Butler5, Shiella Caldejon5, Mike Chapin5, Suvro Datta5, Nick Dee5, Tsega Desta5, Tim Dolbeare5, Nadezhda Dotson5, Amanda Ebbert5, David Feng5, Xu Feng6, Michael Fisher5, Garrett Gee5, Jeff Goldy5, Lindsey Gourley5, Benjamin W Gregor5, Guangyu Gu5, Nika Hejazinia5, John Hohmann5, Parvinder Hothi2, Robert Howard5, Kevin Joines5, Ali Kriedberg5, Leonard Kuan5, Chris Lau5, Felix Lee5, Hwahyung Lee2, Tracy Lemon5, Fuhui Long5, Naveed Mastan5, Erika Mott5, Chantal Murthy2, Kiet Ngo5, Eric Olson5, Melissa Reding5, Zack Riley5, David Rosen5, David Sandman5, Nadiya Shapovalova5, Clifford R Slaughterbeck5, Andrew Sodt5, Graham Stockdale5, Aaron Szafer5, Wayne Wakeman5, Paul E Wohnoutka5, Steven J White7, Don Marsh7, Robert C Rostomily8,9, Lydia Ng5, Chinh Dang5, Allan Jones5, Bart Keogh6, Haley R Gittleman10, Jill S Barnholtz-Sloan10, Patrick J Cimino11, Megha S Uppin12, C Dirk Keene11, Farrokh R Farrokhi13, Justin D Lathia14, Michael E Berens15, Antonio Iavarone16,17,18, Amy Bernard5, Ed Lein5, John W Phillips5, Steven W Rostad19, Charles Cobbs2, Michael J Hawrylycz1, Greg D Foltz2.   

Abstract

Glioblastoma is an aggressive brain tumor that carries a poor prognosis. The tumor's molecular and cellular landscapes are complex, and their relationships to histologic features routinely used for diagnosis are unclear. We present the Ivy Glioblastoma Atlas, an anatomically based transcriptional atlas of human glioblastoma that aligns individual histologic features with genomic alterations and gene expression patterns, thus assigning molecular information to the most important morphologic hallmarks of the tumor. The atlas and its clinical and genomic database are freely accessible online data resources that will serve as a valuable platform for future investigations of glioblastoma pathogenesis, diagnosis, and treatment.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2018        PMID: 29748285      PMCID: PMC6414061          DOI: 10.1126/science.aaf2666

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  139 in total

1.  Glioblastoma: a prognostic value of AMT-PET?

Authors:  Rolf Bjerkvig; Frits Thorsen
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

2.  Analyzing magnetic resonance imaging data from glioma patients using deep learning.

Authors:  Bjoern Menze; Fabian Isensee; Roland Wiest; Bene Wiestler; Klaus Maier-Hein; Mauricio Reyes; Spyridon Bakas
Journal:  Comput Med Imaging Graph       Date:  2020-12-02       Impact factor: 4.790

3.  Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.

Authors:  Antony H Prabhu; Shiva Kant; Pravin Kesarwani; Kamran Ahmed; Peter Forsyth; Ichiro Nakano; Prakash Chinnaiyan
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

4.  Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Authors:  Shuang G Zhao; Menggang Yu; Daniel E Spratt; S Laura Chang; Felix Y Feng; Michelle M Kim; Corey W Speers; Brett L Carlson; Ann C Mladek; Theodore S Lawrence; Jann N Sarkaria; Daniel R Wahl
Journal:  Neuro Oncol       Date:  2019-09-06       Impact factor: 12.300

5.  Transcriptional trajectories of human kidney injury progression.

Authors:  Pietro E Cippà; Bo Sun; Jing Liu; Liang Chen; Maarten Naesens; Andrew P McMahon
Journal:  JCI Insight       Date:  2018-11-15

6.  Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.

Authors:  Niha Beig; Kaustav Bera; Prateek Prasanna; Jacob Antunes; Ramon Correa; Salendra Singh; Anas Saeed Bamashmos; Marwa Ismail; Nathaniel Braman; Ruchika Verma; Virginia B Hill; Volodymyr Statsevych; Manmeet S Ahluwalia; Vinay Varadan; Anant Madabhushi; Pallavi Tiwari
Journal:  Clin Cancer Res       Date:  2020-02-20       Impact factor: 12.531

7.  Discovering and interpreting transcriptomic drivers of imaging traits using neural networks.

Authors:  Nova F Smedley; Suzie El-Saden; William Hsu
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

8.  Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma.

Authors:  Shiva Kant; Pravin Kesarwani; Anthony R Guastella; Praveen Kumar; Stewart F Graham; Katie L Buelow; Ichiro Nakano; Prakash Chinnaiyan
Journal:  Mol Cancer Ther       Date:  2020-05-19       Impact factor: 6.261

9.  Towards Population-Based Histologic Stain Normalization of Glioblastoma.

Authors:  Caleb M Grenko; Angela N Viaene; MacLean P Nasrallah; Michael D Feldman; Hamed Akbari; Spyridon Bakas
Journal:  Brainlesion       Date:  2020-05-19

10.  Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS.

Authors:  Samvel K Gularyan; Alexander A Gulin; Ksenia S Anufrieva; Victoria O Shender; Michail I Shakhparonov; Soniya Bastola; Nadezhda V Antipova; Tatiana F Kovalenko; Yury P Rubtsov; Yaroslav A Latyshev; Alexander A Potapov; Marat S Pavlyukov
Journal:  Mol Cell Proteomics       Date:  2020-04-06       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.